Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing-remitting tumefactive multiple sclerosis.

Stephen M Selkirk1, Jiong Shi

  • 1Department of Neurology, University Hospital of Cleveland, OH 44106, USA. stephen_selkirk@hotmail.com

Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Integration of Gait Dysfunction, Amyloid PET, and Plasma Biomarkers for Differentiating Etiological Subtypes in Mild Cognitive Impairment.

CNS neuroscience & therapeutics·2026
Same author

Tumor cell-derived HSP47 promotes pancreatic Cancer metastasis via Homotrimeric collagen-mediated M2 macrophage polarization.

Cellular signalling·2026
Same author

Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer's disease.

Nature communications·2026
Same author

Regional cerebral hypometabolism and pathological heterogeneity in sporadic early onset alzheimer's disease: China Aging and Neurodegenerative Initiative (CANDI) study.

European journal of nuclear medicine and molecular imaging·2026
Same author

Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study.

Pathology, research and practice·2026
Same author

The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsid.

PLoS pathogens·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Tumefactive multiple sclerosis, a rare demyelinating disease, can present as a mass-like lesion. This case shows tumefactive MS evolving into a relapsing-remitting course over six years.

Area of Science:

  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Tumefactive multiple sclerosis (MS) is a rare demyelinating condition.
  • Its typical course involves a solitary, mass-like lesion that may resolve or evolve.

Observation:

  • This report details a unique case of tumefactive MS.
  • The patient exhibited a relapsing-remitting disease course over a six-year period.

Findings:

  • The study documents the natural progression of tumefactive MS.
  • It highlights the transition from an initial tumefactive presentation to a relapsing-remitting pattern.

Implications:

  • This case expands the understanding of tumefactive MS natural history.
  • It suggests a broader spectrum of disease course than previously characterized.

Related Experiment Videos